$SMTI News

Sanara MedTech: From Cash Burner To Profitable Growth

Sanara MedTech Inc. (SMTI) Q1 2026 Earnings Call Transcript

Transcript: Sanara MedTech Q1 2026 Earnings Conference Call

Sanara MedTech Sees Q2 Sales $28.500M-$29.500M vs $28.650M Est

Sanara MedTech Affirms FY2026 Sales Guidance of $116.000M-$121.000M vs $117.300M Est

Sanara MedTech Q1 EPS $0.05 Beats $(0.04) Estimate, Sales $27.799M Beat $26.800M Estimate

Lake Street Initiates Coverage On Sanara MedTech with Buy Rating, Announces Price Target of $32

Sanara MedTech Inc. Q4 2025 Earnings Call Summary

Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...

Sanara MedTech Q4 Earnings Call Highlights

Sanara MedTech Inc. (NASDAQ:SMTI) Stock Slides on Q4 2025 Earnings Miss Despite Reaffirmed 2026 Outlook

Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance

Sanara MedTech Inc. (SMTI) Q4 2025 Earnings Call Transcript

CORRECTION: Sanara MedTech Q4 Adj. EPS $0.09 Misses $0.11 Estimate, Sales $27.546M Beat $27.400M Estimate (Adj EPS Excludes Asset impairment Charges $0.22/Share)

Sanara MedTech Affirms FY2026 Sales Guidance of $116.000M-$121.000M

Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds

Sanara MedTech Announces Publication Of Peer-Reviewed Study Evaluating Economic And Clinical Value Of CellerateRX Surgical Powder In Journal Of Medical Economics

Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates

Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd